![Andre van Hoek](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Andre van Hoek
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Stalar 3, Inc.
![]() Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Director/Miembro de la Junta | 24/01/2011 | - |
Director Financiero/CFO | 24/01/2011 | - | |
Stalar 4, Inc.
![]() Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Director/Miembro de la Junta | 25/01/2011 | - |
Director Financiero/CFO | 25/01/2011 | - |
Historial de carrera de Andre van Hoek
Antiguos cargos conocidos de Andre van Hoek.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CELGENE | Comptroller/Controller/Auditor | - | 30/06/2012 |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Director of Finance/CFO | 2 |
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Sectorial
Finance | 3 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Stalar 3, Inc.
![]() Stalar 3, Inc. Financial ConglomeratesFinance Stalar 3, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private company, foreign & domestic, seeking to become a public company. The firm has been engaged in initial financing and has commenced negotiations with operating entities. It was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
Stalar 4, Inc.
![]() Stalar 4, Inc. Financial ConglomeratesFinance Stalar 4, Inc. operates as a blank check company with no significant operations. The company is formed to pursue a business combination with an operating private foreign or domestic company that is seeking to become a reporting public company. Stalar 4 was founded on November 13, 2007 and is headquartered in New York, NY. | Finance |
- Bolsa de valores
- Insiders
- Andre van Hoek
- Experiencia